Scholar Rock Holding (SRRK) Current Leases (2018 - 2026)
Scholar Rock Holding's (SRRK) quarterly Current Leases came in at $6.1 million in Q1 2026, up 10.53% year-on-year from $5.5 million in Q1 2025, and up 9.48% quarter-over-quarter from $5.6 million in Q4 2025.
Scholar Rock Holding (SRRK) Current Leases (2018 - 2026) Analysis & Trends
Scholar Rock Holding's Current Leases history runs 9 years deep, the most recent figure standing at $6.1 million for Q1 2026.
- On a quarterly basis, Current Leases rose 10.53% year-over-year to $6.1 million in Q1 2026; TTM through Mar 2026 was $6.1 million, a 10.53% increase from a year earlier, with the FY2025 full-year figure at $5.6 million, down 3.88% from the prior year.
- Current Leases grew to $6.1 million in Q1 2026 per SRRK's latest filing, from $5.6 million in the prior quarter.
- Across five years, Current Leases topped out at $8.1 million in Q3 2022 and bottomed at $5.2 million in Q2 2025.
- The 5-year median for Current Leases is $7.2 million (2023), against an average of $6.7 million.
- Across the five-year window, Current Leases surged 34.41% in 2022 and retreated 27.85% in 2025, its largest moves.
- Year by year, Current Leases stood at $7.9 million in 2022, then decreased by 5.65% to $7.4 million in 2023, then retreated by 22.06% to $5.8 million in 2024, then fell by 3.88% to $5.6 million in 2025, then climbed by 9.48% to $6.1 million in 2026.
- Per Business Quant, the three latest SRRK Current Leases figures stand at $6.1 million (Q1 2026), $5.6 million (Q4 2025), and $5.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Scholar Rock Holding | 6.30 Bn | 6.30 Bn | - | 6.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.08 Mn |
| Dec 31, 2025 | 5.55 Mn |
| Sep 30, 2025 | 5.33 Mn |
| Jun 30, 2025 | 5.21 Mn |
| Mar 31, 2025 | 5.50 Mn |
| Dec 31, 2024 | 5.77 Mn |
| Sep 30, 2024 | 6.04 Mn |
| Jun 30, 2024 | 6.20 Mn |
| Mar 31, 2024 | 7.62 Mn |
| Dec 31, 2023 | 7.41 Mn |
| Sep 30, 2023 | 7.20 Mn |
| Jun 30, 2023 | 7.28 Mn |
| Mar 31, 2023 | 7.64 Mn |
| Dec 31, 2022 | 7.85 Mn |
| Sep 30, 2022 | 8.06 Mn |
| Jun 30, 2022 | 7.84 Mn |
| Mar 31, 2022 | 7.62 Mn |
| Dec 31, 2021 | 7.41 Mn |
| Sep 30, 2021 | 7.20 Mn |
| Jun 30, 2021 | 7.00 Mn |